Novel LIAS variants in a patient with epilepsy and profound developmental disabilities

Parith Wongkittichote, Chanseyha Chhay, Gazelle Zerafati-Jahromi, Judith L. Weisenberg, Ali Mian, Laran T. Jensen, Dorothy K. Grange

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Multiple mitochondrial enzymes employ lipoic acid as a coenzyme. Pathogenic variants in LIAS, encoding lipoic acid synthase (LIAS), are associated with autosomal recessive LIAS-related disorder (OMIM# 614462). This disorder is characterized by infantile-onset hypotonia, profound psychomotor delay, epileptic encephalopathy, nonketotic hyperglycinemia, and lactic acidosis. We present the case of a 20-year-old female who experienced developmental deficits at the age of 6 months and began to have seizures at 3 years of age. Exome sequencing revealed compound heterozygous novel variants in LIAS, designated c.277delC (p.Leu93Ter) and c.542A > T (p.Asp181Val). The p.Leu93Ter variant is predicted to cause loss of function due to the severe truncation of the encoded protein. To examine the p.Asp181Val variant, functional analysis was performed using Baker's yeast (Saccharomyces cerevisiae) lacking LIP5, the homologue of human LIAS. Wild-type LIAS promoted oxidative growth of the lip5∆ yeast strain. In contrast, lip5∆ yeast expressing p.Asp181Val exhibited poor growth, similar to known pathogenic variants, p.Asp215Glu and p.Met310Thr. Our work has expanded the phenotypic and genotypic spectrum of LIAS-related disorder and established the use of the yeast model as a system for functional study of novel missense variants in LIAS.

Original languageEnglish
Article number107373
JournalMolecular genetics and metabolism
Volume138
Issue number3
DOIs
StatePublished - Mar 2023

Keywords

  • Developmental delay
  • Epilepsy
  • LIAS-related disorder
  • Lipoic acid biosynthesis
  • Mitochondrial disorder
  • Nonketotic hyperglycinemia

Fingerprint

Dive into the research topics of 'Novel LIAS variants in a patient with epilepsy and profound developmental disabilities'. Together they form a unique fingerprint.

Cite this